BeMORE: A novel method for detection of adverse fetal effects induced by drugs

Ilan Matok, Amalia Levy, Rafael Gorodischer, Eitan Lunenfeld, Yehuda Limony, Gideon Koren*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.

Original languageEnglish
Pages (from-to)40-42
Number of pages3
JournalCurrent Drug Safety
Volume6
Issue number1
DOIs
StatePublished - 2011
Externally publishedYes

Keywords

  • Fetus
  • Malformations
  • Medication
  • Neonate
  • Pregnancy

Fingerprint

Dive into the research topics of 'BeMORE: A novel method for detection of adverse fetal effects induced by drugs'. Together they form a unique fingerprint.

Cite this